<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">systhiper</journal-id><journal-title-group><journal-title xml:lang="ru">Системные гипертензии</journal-title><trans-title-group xml:lang="en"><trans-title>Systemic Hypertension</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2075-082X</issn><issn pub-type="epub">2542-2189</issn><publisher><publisher-name>LLC «ИнтерМедсервис»</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">systhiper-347</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КАРДИОЛОГИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CARDIOLOGY</subject></subj-group></article-categories><title-group><article-title>Влияние петлевых диуретиков‌‌ с различным периодом полувыведения на динамику изменения натрийуреза у гипертоников с разным профилем артериального давления</article-title><trans-title-group xml:lang="en"><trans-title>Effects of loop diureticswith differenthalf-elimination times on natriuresis changes in hypertensive patients with different blood pressure profile</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Арутюнов</surname><given-names>Г. П.</given-names></name><name name-style="western" xml:lang="en"><surname>Arutyunov</surname><given-names>G. P.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Драгунов</surname><given-names>Д. О.</given-names></name><name name-style="western" xml:lang="en"><surname>Dragunov</surname><given-names>D. O.</given-names></name></name-alternatives><email xlink:type="simple">tamops2211@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Соколова</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Sokolova</surname><given-names>A. V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff xml:lang="ru" id="aff-1"><institution>ГБОУ ВПО РНИМУ им. Н.И.Пирогова Минздрава России</institution><country>Russian Federation</country></aff><pub-date pub-type="collection"><year>2014</year></pub-date><pub-date pub-type="epub"><day>23</day><month>12</month><year>2022</year></pub-date><volume>11</volume><issue>2</issue><fpage>23</fpage><lpage>28</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Арутюнов Г.П., Драгунов Д.О., Соколова А.В., 2022</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="ru">Арутюнов Г.П., Драгунов Д.О., Соколова А.В.</copyright-holder><copyright-holder xml:lang="en">Arutyunov G.P., Dragunov D.O., Sokolova A.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.syst-hypertension.ru/jour/article/view/347">https://www.syst-hypertension.ru/jour/article/view/347</self-uri><abstract><p>Цель исследования - изучение взаимосвязи кривых натрийурез-время с суточным профилем артериального давления (АД), а также изучение влияния мочегонной терапии на динамику натрийуреза и профиль АД.Материалы и методы. Из группы пациентов, участвовавших в ранее проведенном нами исследовании по изучению типов натрийуретических кривых, были отобраны пациенты (n=56), которые имели признаки ухудшения хронической сердечной недостаточности и которым требовалось назначение мочегонной терапии. Пациенты получали торасемид SR или IR. Результаты. Показано, что у пациентов может изменяться тип натрийуретической кривой, а также профиль АД. Ухудшение натрийуреза чаще и раньше по времени наступает в группе торасемида IR по сравнению с группой торасемида SR (p&lt;0,05). Наибольшим образом тип кривой связан с повышением уровня белка ТНР, переходом из одного типа кривой в другой, длительностью гипертонической болезни (ГБ). Показано, что чем длительнее анамнез ГБ, тем выше уровень влияния ангиотензина II (АТ II). Вероятность перехода из 3-го типа кривой ко 2-му - 83,93% (отношение шансов - ОШ 11,667); вероятность перехода из 2-го типа кривой к 1-му - 92,86% (ОШ 120,0). Установлено, что основными предикторами, изменяющими профиль АД в худшую сторону, являются: чрезмерное употребление соли (ОШ 1,4), длительность ГБ (ОШ 3,5), тип натрийуретической кривой (ОШ 3,4). Вероятность изменения суточного профиля АД на non-dipper или night-peaker составляет 83,3% (ОШ 21,0).Заключение. С течением времени и при наличии уже измененного натрийуреза происходит достоверное ухудшение экскреции натрия, увеличивается экскреция ТНР, что является маркером прогрессирующего фиброза тубулоинтерстициальной ткани почек, нарастает активность АТ II и изменяется профиль АД, что доказывает необходимость мониторирования натрийуреза.</p></abstract><trans-abstract xml:lang="en"><p>The aim is to study the interaction of natriuresis curves with 24-h blood pressure (BP) profile, as well as to study the effect of diuretic therapy on natriuresis changes and on the BP profile.Materials and methods. From the group of patients who participated in the study on the types of natriuretic curves we selected patients (n=56) with signs of deterioration of chronic heart failure (CHF) and who should be prescribed diuretic therapy. Patients received torasemide SR or IR. Results. It was demonstrated that type of natriuresis curves and blood pressure (BP) profile could be changed. Deterioration of natriuresis more oftener and earlier were observed in torasemide IR group compared with torasemide SR group of patients (p&lt;0,05).The type of natriuresis curve is associated with increasing of Tamm-Horsfall protein (THP) level, switching from one to another type of curveand duration of GB. It was shown that long-lasting hypertension (GB) was associated with high level of angiotensin II (AII). The likelihood of changes in 3ed curve to 2ed one is 83,93% (ОR 11,667); the likelihood ofchanges in 2ed curve to 1st one - 92,86% (ОR 120,00). The main predictors of BP profile could cause side effects were over use of salt (ОR 1,4), long-lasting GB (ОR 3,5), the type of natriuresis curves (OR 3,4). The likelihood of daily BP non-dipper or night-peaker profile to be changed is 83,3% (OR 21,00).Conclusion. The significant impairment of sodium excretion and increasing THP excretion are the markers of progressive renal tubulointerstitial fibrosis in the patients with modified natriuresis. The activity of AII is increasing and BP profile is changing and all these changes prove the necessity for monitoring natriuresis.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>натрийурез</kwd><kwd>белок ТНР</kwd><kwd>ангиотензин II</kwd><kwd>тубулоинтерстициальная ткань</kwd><kwd>профиль артериального давления</kwd><kwd>TH protein</kwd><kwd>AII</kwd><kwd>BP profile</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Арутюнов Г.П., Оганезова Л.Г., Драгунов Д.О. Патент №2490636. Электронные бюллетени - изобретения и полезные модели. 2013; 23.</mixed-citation><mixed-citation xml:lang="en">Арутюнов Г.П., Оганезова Л.Г., Драгунов Д.О. Патент №2490636. Электронные бюллетени - изобретения и полезные модели. 2013; 23.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Fukuda M, Kimura G. Salt sensitivity and nondippers in chronic kidney disease. Curr Hypertens Reports 2012; 14 (5): 382-7.</mixed-citation><mixed-citation xml:lang="en">Fukuda M, Kimura G. Salt sensitivity and nondippers in chronic kidney disease. Curr Hypertens Reports 2012; 14 (5): 382-7.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Арутюнов Г.П., Оганезова Л.Г., Драгунов Д.О., Соколова А.В. Эпидемиология артериальной гипертензии: ее взаимосвязь с поражением почек и феноменом соль - чувствительности. Клин. нефрология. 2013; 2: 67-70.</mixed-citation><mixed-citation xml:lang="en">Арутюнов Г.П., Оганезова Л.Г., Драгунов Д.О., Соколова А.В. Эпидемиология артериальной гипертензии: ее взаимосвязь с поражением почек и феноменом соль - чувствительности. Клин. нефрология. 2013; 2: 67-70.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Deetjen P, Kramer K. Die Abhangigkeit des O2 - Verbrauches der Niere von der Na - Ruckresorption. Pflugers Arch. Eur J Physiol 1961; 273: 636-50.</mixed-citation><mixed-citation xml:lang="en">Deetjen P, Kramer K. Die Abhangigkeit des O2 - Verbrauches der Niere von der Na - Ruckresorption. Pflugers Arch. Eur J Physiol 1961; 273: 636-50.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Шмидт Р., Тевса Г. Физиология человека. В 3 т. Т. 3. Пер. с англ. 3-е изд. М.: Мир, 2005; с. 788-98.</mixed-citation><mixed-citation xml:lang="en">Шмидт Р., Тевса Г. Физиология человека. В 3 т. Т. 3. Пер. с англ. 3-е изд. М.: Мир, 2005; с. 788-98.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Weinberger M.H. Salt sensitivity of blood pressure in humans. Hypertens 1996; 27: 481-90.</mixed-citation><mixed-citation xml:lang="en">Weinberger M.H. Salt sensitivity of blood pressure in humans. Hypertens 1996; 27: 481-90.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Rodriguez-Iturbe B.О, Vaziri N.D. Salt - sensitive hypertension - update on novel findings. Nephrol Dial Transplant 2007; 22 (4): 992-5.</mixed-citation><mixed-citation xml:lang="en">Rodriguez-Iturbe B.О, Vaziri N.D. Salt - sensitive hypertension - update on novel findings. Nephrol Dial Transplant 2007; 22 (4): 992-5.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Preddie D.C, Markowitz G.S, Radhakrishnan J. Mycophenolatemofetil for the treatment of interstitial nephritis. Clin J Am Soc Nephrol 2006; 1: 718-22.</mixed-citation><mixed-citation xml:lang="en">Preddie D.C, Markowitz G.S, Radhakrishnan J. Mycophenolatemofetil for the treatment of interstitial nephritis. Clin J Am Soc Nephrol 2006; 1: 718-22.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Álvarez V, Quiroz Y, Nava M et al. Overload proteinuria is followed by salt - sensitive hypertension caused by renal infiltration of immune cells. Am J Physiol Renal Physiol 2002; 283: 1132-41.</mixed-citation><mixed-citation xml:lang="en">Álvarez V, Quiroz Y, Nava M et al. Overload proteinuria is followed by salt - sensitive hypertension caused by renal infiltration of immune cells. Am J Physiol Renal Physiol 2002; 283: 1132-41.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Quiroz Y, Johnson R.J, Rodriguez-Iturbe B. The role of T cells in the pathogenesis of primary hypertension published online ahead of print. Nephrol Dial Transplant 2012; 27 (4): 2-5.</mixed-citation><mixed-citation xml:lang="en">Quiroz Y, Johnson R.J, Rodriguez-Iturbe B. The role of T cells in the pathogenesis of primary hypertension published online ahead of print. Nephrol Dial Transplant 2012; 27 (4): 2-5.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Navar L.G, Nishiyama A. Why are angiotensin concentrations so high in the kidney? Curr Opin Nephrol Hypertens 2004; 13: 107-15.</mixed-citation><mixed-citation xml:lang="en">Navar L.G, Nishiyama A. Why are angiotensin concentrations so high in the kidney? Curr Opin Nephrol Hypertens 2004; 13: 107-15.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Paul M, Mehr A.P, Kreutz R. Physiology of local renin - angiotensin systems. Physiol Rev 2006; 86: 747-803.</mixed-citation><mixed-citation xml:lang="en">Paul M, Mehr A.P, Kreutz R. Physiology of local renin - angiotensin systems. Physiol Rev 2006; 86: 747-803.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Kobori H, Nangaku M, Navar L.G et al. The intrarenal renin - angiotensin system: from physiology to the pathobiology of hypertension and kidney disease. Pharmacol Rev 2007; 59: 251-87.</mixed-citation><mixed-citation xml:lang="en">Kobori H, Nangaku M, Navar L.G et al. The intrarenal renin - angiotensin system: from physiology to the pathobiology of hypertension and kidney disease. Pharmacol Rev 2007; 59: 251-87.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Visser F.W, Boonstra A.H, Titia Lely А et al. Renal response to angiotensin II is blunted in sodium - sensitive normotensive men. Am J Hypertens 2008; 21 (3): 323-8.</mixed-citation><mixed-citation xml:lang="en">Visser F.W, Boonstra A.H, Titia Lely А et al. Renal response to angiotensin II is blunted in sodium - sensitive normotensive men. Am J Hypertens 2008; 21 (3): 323-8.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Kimura G, Brenner B.M. A method for distinguishing salt - sensitive from non - salt - sensitive forms of human and experimental hypertension. Curr Opin Nephrol Hypertens 1993; 2: 341-9.</mixed-citation><mixed-citation xml:lang="en">Kimura G, Brenner B.M. A method for distinguishing salt - sensitive from non - salt - sensitive forms of human and experimental hypertension. Curr Opin Nephrol Hypertens 1993; 2: 341-9.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Johnson R.J, Schreiner G. Hypothesis: is essential hypertension an acquired tubulointerstitial renal disease? Kidney Int 1997; 52: 1169-79.</mixed-citation><mixed-citation xml:lang="en">Johnson R.J, Schreiner G. Hypothesis: is essential hypertension an acquired tubulointerstitial renal disease? Kidney Int 1997; 52: 1169-79.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Lombardi D, Gordon K.L, Polinsky P et al. Salt - sensitive hypertension develops after short - term exposure to angiotensin II. Hypertens 1999; 33: 1013-9.</mixed-citation><mixed-citation xml:lang="en">Lombardi D, Gordon K.L, Polinsky P et al. Salt - sensitive hypertension develops after short - term exposure to angiotensin II. Hypertens 1999; 33: 1013-9.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Johnson R.J, Gordon K.L, Suga S et al. Renal injury and salt - sensitive hypertension after exposure to catecholamines. Hypertens 1999; 34: 151-9.</mixed-citation><mixed-citation xml:lang="en">Johnson R.J, Gordon K.L, Suga S et al. Renal injury and salt - sensitive hypertension after exposure to catecholamines. Hypertens 1999; 34: 151-9.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Chiolero A, Würzner G, Burnier M. Renal determinants of the salt sensitivity of blood pressure. Nephrol Dial Transplant 2001; 16 (3): 452-8.</mixed-citation><mixed-citation xml:lang="en">Chiolero A, Würzner G, Burnier M. Renal determinants of the salt sensitivity of blood pressure. Nephrol Dial Transplant 2001; 16 (3): 452-8.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Chiolero A, Maillard M, Nussberger J et al. Proximal sodium reabsorption: an independent determinant of blood pressure response to salt. Hypertens 2000; 36: 631-7.</mixed-citation><mixed-citation xml:lang="en">Chiolero A, Maillard M, Nussberger J et al. Proximal sodium reabsorption: an independent determinant of blood pressure response to salt. Hypertens 2000; 36: 631-7.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Strazzullo P, Galletti F, Barba G. Altered renal handling of sodium in human hypertension short review of the evidence. Hypertens 2003; 41: 1000-5.</mixed-citation><mixed-citation xml:lang="en">Strazzullo P, Galletti F, Barba G. Altered renal handling of sodium in human hypertension short review of the evidence. Hypertens 2003; 41: 1000-5.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Kimura G, Dohi Y, Fukuda M. Salt sensitivity and circadian rhythm of blood pressure: the keys to connect CKD with cardiovasucular events. Hypertens Research 2010; 33: 515-20.</mixed-citation><mixed-citation xml:lang="en">Kimura G, Dohi Y, Fukuda M. Salt sensitivity and circadian rhythm of blood pressure: the keys to connect CKD with cardiovasucular events. Hypertens Research 2010; 33: 515-20.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Higashi Y, Oshima T, Ozono R et al. Nocturnal decline in blood pressure is attenuated by NaCl loading in salt - sensitive patients with essential hypertension noninvasive 24-hour ambulatory blood pressure monitoring. Hypertens 1997; 30: 163-7.</mixed-citation><mixed-citation xml:lang="en">Higashi Y, Oshima T, Ozono R et al. Nocturnal decline in blood pressure is attenuated by NaCl loading in salt - sensitive patients with essential hypertension noninvasive 24-hour ambulatory blood pressure monitoring. Hypertens 1997; 30: 163-7.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Rosón M.I, Cavallero S, Della Penna S et al. Acute sodium overload produces renal tubulointerstitial inflammation in normal rats. Kidney International 2006; 70: 1439-47.</mixed-citation><mixed-citation xml:lang="en">Rosón M.I, Cavallero S, Della Penna S et al. Acute sodium overload produces renal tubulointerstitial inflammation in normal rats. Kidney International 2006; 70: 1439-47.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
